Respicardia, Inc. Pivotal Trial of the remedē System

NCT01816776 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Apnea, Central
Sleep Disordered Breathing
Heart Failure

Interventions

DEVICE: Treatment Group (transvenous stimulation of the phrenic nerve)
DEVICE: Control Group (Optimal Medical Therapy)

Sponsor

Respicardia, Inc.